Xacduro

No Patient Assistance Program (PAP) Identified for Xacduro: Access Guide for Sulbactam Durlobactam

Xacduro (sulbactam durlobactam) currently has no dedicated manufacturer patient assistance program (PAP) from Menarini Group, meaning there is no standard program offering the drug at low or no cost based on income eligibility.[1] This guide explains what this means for patients, details the drug's use, explores alternative cost-saving options like Medicare support, and provides steps for accessing affordable care.[1][2]

About Xacduro (Sulbactam Durlobactam)

Xacduro is an intravenous antibiotic co-packaged product (sulbactam for injection and durlobactam for injection) approved for treating hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in adults caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex, including multidrug-resistant strains.[1] It is the first and only treatment specifically targeting these infections, showing non-inferiority to colistin for 28-day all-cause mortality and higher clinical cure rates.[1] Administered in hospitals, Xacduro has a favorable safety profile but is reserved for serious cases where other antibiotics may fail.[1]

As a hospital-administered drug, costs are often covered under inpatient stays, but out-of-pocket expenses can arise for uninsured patients or those with high deductibles. Without a PAP, patients must rely on insurance, government programs, or discounts.[1][2]

Who Qualifies for Assistance?

Since no PAP is identified for Xacduro, there are no specific income thresholds, required documents, or application processes from the manufacturer.[1] Menarini Group does not list a program on official resources, and searches confirm 'No PAP identified.'[1][3]

However, many patients may qualify for broader assistance:

• Uninsured or low-income: Explore state programs or general charity care.
• Medicare patients: Part D coverage, Extra Help, or the Medicare Prescription Payment Plan (spreads costs up to $2,000 out-of-pocket cap in 2025).[2]
• Commercial insurance: Co-pay cards from similar programs (though not available for Xacduro) or GoodRx discounts.[2]

Income Eligibility Breakdown

No manufacturer-specific income limits exist. For reference, general programs like Medicare Extra Help use Federal Poverty Level (FPL) guidelines:

Notes: FPL adjusts yearly; Extra Help offers no deductible, low copays. Xacduro not typically outpatient, so hospital billing applies.[2] Always verify current FPL at medicare.gov.

Insurance Requirements

No PAP insurance rules apply since none exists.[1] Key considerations:

• Medicare: Covered under Part A (hospital) for HABP/VABP; Part D for any outpatient use. Use Extra Help if income-qualified (limits premiums/deductibles/copays). New 2025 Payment Plan spreads costs.[2]
• Commercial/Private: Check prior authorization; hospital stays often covered.
• Medicaid: Usually covers hospital antibiotics fully for eligible patients.
• Uninsured: Hospitals may offer financial aid; contact billing department.[2][3]

Xacduro is distributed via specialty channels like ASD Healthcare (1-800-746-6273), Cardinal Health, or McKesson—ask providers for samples or bridging supply.[3]

Step-by-Step Guide to Access Xacduro Affordably

1. Confirm Prescription: Discuss with your doctor if Xacduro is appropriate for your Acinetobacter infection.[1]
2. Check Insurance: Contact your plan for coverage details, prior auth, or appeals. For Medicare, review Part D options during Open Enrollment.[2]
3. Apply for Extra Help (Medicare): Visit ssa.gov or call 1-800-MEDICARE. Provide income/assets proof; approval reduces costs significantly.[2]
4. Explore Discounts: Use GoodRx for any outpatient fills (though primarily hospital-use).[2] Inquire about hospital charity care or payment plans.
5. Contact Distributors: For urgent needs, healthcare providers can order via ASD (1-800-746-6273), Cardinal (1-866-677-4844), or McKesson (1-877-625-2566).[3]
6. State Programs: Search Medicare's tool for State Pharmaceutical Assistance Programs (e.g., Pennsylvania PACE).[2]
7. Manufacturer Inquiry: Call Menarini Group or visit xacduro.com to ask about unlisted support (none confirmed).[1]

Timeline and Delivery

No PAP processing time as none exists. Hospital delivery is immediate upon order.[1][3]

• Insurance verification: 1-5 days.
• Extra Help approval: 4-6 weeks (expedited possible).[2]
• Distributors ship to hospitals within 24-48 hours.[3] Xacduro vials (NDC 68547-111-10) are reconstituted for IV use in clinical settings—no home delivery.[1][3]

Alternatives if Denied Coverage

• Switch Antibiotics: Colistin (comparator in trials) or others per doctor.[1]
• Appeal Insurance: Provide lab confirmation of susceptible Acinetobacter.[1]
• Financial Aid: Hospital indigent programs, NeedyMeds.org, or RxAssist.org for general help.
• Clinical Trials: Search clinicaltrials.gov for Xacduro studies.
• Medicare Changes: Enroll in better Part D plan; use $2,000 cap.[2]

Disclaimer

This guide is for informational purposes only and not medical/financial advice. No PAP exists for Xacduro per available data (as of 2026).[1] Consult your healthcare provider, pharmacist, or Medicare counselor. Eligibility/costs vary; verify with official sources. Menarini Group reserves rights to future programs. Word count: 942.